Genentech, Inc. et al v. Sanofi-Aventis Deutschland GMBH et al
Filing
624
ORDER granting extention re: fees and costs (tf, COURT STAFF) (Filed on 5/2/2011)
1 Counsel Listed on Following Page
2
3
4
5
6
7
8
UNITED STATES DISTRICT COURT
9
NORTHERN DISTRICT OF CALIFORNIA
10
SAN FRANCISCO DIVISION
11
12
13 SANOFI-AVENTIS DEUTSCHLAND
GMBH,
14
Plaintiff,
15
vs.
16
GENENTECH, INC. and BIOGEN IDEC
17 INC.,
18
19
Defendants.
CASE NOS. 08-cv-4909-SI (BZ),
09-cv-4919-SI
STIPULATION AND [PROPOSED] ORDER
ENLARGING TIME ON PROCEEDINGS
ON COSTS, ATTORNEYS’ FEES, AND
SANCTIONS
[Civil L.R. 6-1, 6-2]
Honorable Susan Illston
United States District Judge
20
21
22
23
24
25
26
27
28
01731.51443/4118152.1
Case Nos. 08-cv-4909-SI (BZ); 09-cv-4919-SI
STIPULATION AND [PROPOSED] ORDER ENLARGING TIME ON
PROCEEDINGS ON COSTS, ATTORNEYS’ FEES, AND SANCTIONS
1
QUINN EMANUEL URQUHART &
2 SULLIVAN, LLP
Charles K. Verhoeven (Bar No. 170151)
3
charlesverhoeven@quinnemanuel.com
50 California Street, 22nd Floor
4 San Francisco, California 94111
Telephone: (415) 875-6600
5 Facsimile: (415) 875-6700
6
Victoria F. Maroulis (Bar No. 202603)
victoriamaroulis@quinnemanuel.com
7
Gabriel S. Gross (Bar No. 254672)
gabegross@quinnemanuel.com
8 555 Twin Dolphin Drive, 5th Floor
Redwood Shores, California 94065-2139
9 Telephone: (650) 801-5000
Facsimile: (650) 801-5100
10
Attorneys for Defendant Genentech, Inc.
11
KILPATRICK TOWNSEND & STOCKTON
12 LLP
James G. Gilliland (Bar No. 107988)
13
jgilliland@kilpatricktownsend.com
Two Embarcadero Center, Eighth Floor
14
San Francisco, CA 94111
15 Telephone: (415) 576-0200
Facsimile: (415) 576-0300
16
Anne M. Rogaski (Bar No. 184754)
17
arogaski@kilpatricktownsend.com
379 Lytton Avenue
18
Palo Alto, CA 94301
19 Telephone: (650) 326-2400
Facsimile: (650) 326-2422
20
21
FOLEY HOAG LLP
Donald R. Ware (pro hac vice)
dware@foleyhoag.com
Claire Laporte (pro hac vice)
claporte@foleyhoag.com
Jeremy A. Younkin (pro hac vice)
jyounkin@foleyhoag.com
Seaport World Trade Center West
155 Seaport Boulevard
Boston, MA 02210-2600
Telephone: (617) 832-1180
Facsimile: (617) 832-7000
Attorneys for Defendant Biogen Idec Inc.
HARVEY SISKIND LLP
D. Peter Harvey (Bar No. 55712)
pharvey@harveysiskind.com
Naomi Jane Gray (Bar No. 230171)
ngray@harveysiskind.com
Four Embarcadero Center, 39th Floor
San Francisco, California 94111
Telephone: (415) 354-0100
Facsimile: (415) 391-7124
FITZPATRICK, CELLA, HARPER &
SCINTO
William E. Solander (admitted pro hac vice)
wsolander@fchs.com
Dominick A. Conde (admitted pro hac vice)
dconde@fchs.com
Peter D. Shapiro (admitted pro hac vice)
pshapiro@fchs.com
Joshua A. Davis (admitted pro hac vice)
jdavis@fchs.com
1290 Avenue of the Americas
New York, New York 10104
Telephone: 212-218-2100
Facsimile: 212-218-2200
22
23
Attorneys for Plaintiff Sanofi-Aventis
Deutschland GmbH
24
25
26
27
28
01731.51443/4118152.1
Case Nos. 08-cv-4909-SI (BZ); 09-cv-4919-SI
2
STIPULATION AND [PROPOSED] ORDER ENLARGING TIME ON
PROCEEDINGS ON COSTS, ATTORNEYS’ FEES, AND SANCTIONS
1
Pursuant to Civil Local Rules 6-1 and 6-2, Plaintiff Sanofi-Aventis Deutschland GmbH
2 ("Sanofi") and Defendants Genentech, Inc. ("Genentech") and Biogen Idec Inc. ("Biogen")
3 respectfully request that the Court enter the following stipulation regarding proceedings on costs,
4 attorneys’ fees, and sanctions. The parties now AGREE AND STIPULATE to enlarge time on these
5 proceedings until after disposition of both Sanofi’s appeal of this Court’s final judgment of non6 infringement and Defendants’ counterclaims of invalidity and unenforceability.
7
1.
Reason for the Request
8
On April 21, 2011, the Court granted Sanofi’s motion for entry of final judgment of non-
9 infringement as to Rituxan® and Avastin® under Federal Rule of Civil Procedure 54(b). (D.N.
10 621.) The Court stayed further proceedings, including Defendants’ counterclaims of invalidity and
11 unenforceability, pending the outcome of any appeal of the Court’s final judgment of non12 infringement. (Id.) Under Civil Local Rule 54-1, Defendants must file a bill of costs within 14 days
13 of the Court’s entry of final judgment, or by May 5, 2011. Under Civil Local Rule 54-5, motions for
14 awards of attorneys’ fees are also due within 14 days of entry of judgment. Under Civil Local Rule
15 7-8(d), motions for sanctions also must be filed within 14 days of entry of judgment. The parties
16 now seek to stay these proceedings on costs and fees, as well as any proceedings on sanctions under
17 Fed. R. Civ. P. 11 and Civil Local Rule 7-8(d) and on whether this is an “exceptional case” under 35
18 U.S.C. § 285, until after disposition of Sanofi’s appeal of this Court’s final judgment of non19 infringement and Defendants’ counterclaims of invalidity and unenforceability. An order staying
20 these proceedings will conserve judicial resources in the event that any aspect of the Court’s Rule
21 54(b) judgment is reversed and remanded on appeal and because further proceedings on Defendants’
22 pending counterclaims are required.
23
2.
Prior Time Modifications
24
The time for Sanofi to answer or otherwise respond to the Complaint was previously
25 extended. The briefing and hearing schedule for Motions to Dismiss for Lack of Jurisdiction
26 brought by Sanofi and its former co-defendants was temporarily vacated. The briefing and hearing
27 schedule for Genentech's Motion To Disqualify McDonnell Boehnen Hulbert and Berghoff LLP was
28 extended by four weeks. The briefing and hearing schedule for Sanofi’s Motion for Leave to
01731.51443/4118152.1
Case Nos. 08-cv-4909-SI (BZ); 09-cv-4919-SI
3
STIPULATION AND [PROPOSED] ORDER ENLARGING TIME ON
PROCEEDINGS ON COSTS, ATTORNEYS’ FEES, AND SANCTIONS
1 Amend Its Pleadings and Infringement Contentions was previously extended by five weeks and then
2 extended again by seven weeks. The Markman hearing and tutorial were previously continued by
3 45 days. The date for Sanofi’s oppositions to Defendants’ motions for summary judgment was
4 extended by approximately three weeks. The date for Defendants’ replies to Sanofi’s summary
5 judgment oppositions was extended by one week. The deadline to conduct ADR was originally
6 extended by about 40 days. The deadline for conducting ADR was again extended by two months.
7 The schedule for the Further Case Management Conference was previously vacated and rescheduled
8 for five weeks later and then extended again by two weeks. The hearing schedule for the Motion for
9 Summary Judgment, Motion for Summary Judgment of Invalidity for Lack of Written Description,
10 Motion to Compel, Motion to Amend/Correct Infringement Contentions, and Motion to Strike was
11 extended by two weeks. The deadline for filing dispositive motions was extended three weeks and
12 the deadline for the last day on which dispositive motions could be heard was extended four weeks.
13 The Court expedited the schedule for considering Sanofi’s Motion for Entry of Final Judgment by
14 two weeks.
15
3.
Effect of Requested Modification
16
The requested modification will have no effect on the rest of the schedule in this action.
17
So Stipulated.
18
19
20
21
22
23
24
25
26
27
28
01731.51443/4118152.1
Case Nos. 08-cv-4909-SI (BZ); 09-cv-4919-SI
4
STIPULATION AND [PROPOSED] ORDER ENLARGING TIME ON
PROCEEDINGS ON COSTS, ATTORNEYS’ FEES, AND SANCTIONS
1
DATED: April 29, 2011
2
HARVEY SISKIND LLP
FITZPATRICK, CELLA, HARPER & SCINTO
3
By s/ William E. Solander
William E. Solander
Attorneys for Plaintiff Sanofi-Aventis
Deutschland GmbH
4
5
6
7
8 DATED: April 29, 2011
QUINN EMANUEL URQUHART &
SULLIVAN, LLP
9
10
By s/ Victoria F. Maroulis
Victoria F. Maroulis
Attorneys for Defendant Genentech, Inc.
11
12
13
DATED: April 29, 2011
14
TOWNSEND TOWNSEND AND CREW LLP
FOLEY HOAG LLP
15
By s/ Claire Laporte
Claire Laporte
Attorneys for Defendant Biogen Idec Inc.
16
17
18
19
20
PURSUANT TO STIPULATION, IT IS SO ORDERED.
21
22
23
24
2
DATED: May__, 2010
___________________________________________
Susan Illston
United States District Court Judge
25
26
27
28
01731.51443/4118152.1
Case Nos. 08-cv-4909-SI (BZ); 09-cv-4919-SI
5
STIPULATION AND [PROPOSED] ORDER ENLARGING TIME ON
PROCEEDINGS ON COSTS, ATTORNEYS’ FEES, AND SANCTIONS
1
2
I, Victoria F. Maroulis, am the ECF User whose identification and password are being used
3 to file this document. Pursuant to General Order 45.X.B, I hereby attest that counsel for Plaintiff
4 has concurred in this filing.
5
6
7 DATED: April 29, 2011
QUINN EMANUEL URQUHART &
SULLIVAN, LLP
8
9
10
By s/ Victoria F. Maroulis
Victoria F. Maroulis
Attorneys for Defendant Genentech, Inc.
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
01731.51443/4118152.1
Case Nos. 08-cv-4909-SI (BZ); 09-cv-4919-SI
6
STIPULATION AND [PROPOSED] ORDER ENLARGING TIME ON
PROCEEDINGS ON COSTS, ATTORNEYS’ FEES, AND SANCTIONS
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?